Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Large-scale testing (Phase 3)WithdrawnNCT01826864What this trial is testingSargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II MelanomaWho this might be right forStage IB MelanomaStage IIA MelanomaStage IIB Melanoma+1 more Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05655312What this trial is testingMC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced MelanomaWho this might be right forRecurrent Melanoma (Skin)Metastatic MelanomaMelanoma Stage IV+1 more Perspective Therapeutics 300
Early research (Phase 1)Ended earlyNCT02012231What this trial is testingPhase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.Who this might be right forMelanomaThyroid CancerColorectal Cancer+4 more Fore Biotherapeutics 5
Large-scale testing (Phase 3)Study completedNCT01989572What this trial is testingSargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By SurgeryWho this might be right forIris MelanomaMedium/Large Size Posterior Uveal MelanomaMucosal Melanoma+17 more National Cancer Institute (NCI) 815
Testing effectiveness (Phase 2)Looking for participantsNCT05251389What this trial is testingFMT to Convert Response to ImmunotherapyWho this might be right forMelanoma Stage IIIMelanoma Stage IV The Netherlands Cancer Institute 24
Not applicableStudy completedNCT03028948What this trial is testingInteractive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With MelanomaWho this might be right forStage 0 Skin MelanomaStage I Skin MelanomaStage IA Skin Melanoma+9 more Rutgers, The State University of New Jersey 485
Not applicableStudy completedNCT00897442What this trial is testingCollecting Tumor Samples From Patients With Gynecological TumorsWho this might be right forBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more Gynecologic Oncology Group 275
Testing effectiveness (Phase 2)Study completedNCT02678741What this trial is testingMulti-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.Who this might be right forMetastatic Melanoma Elios Therapeutics, LLC 26
Testing effectiveness (Phase 2)UnknownNCT05955105What this trial is testingILB2109 and Toripalimab in Patients With Advanced Solid MalignanciesWho this might be right forHead and Neck CancerCervical CancerEndometrial Cancer+7 more Innolake Biopharm 200
Testing effectiveness (Phase 2)Study completedNCT05061017What this trial is testingPixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC)Who this might be right forNSCLCMetastatic Colorectal CarcinomaRefractory Melanoma Diwakar Davar 13
Testing effectiveness (Phase 2)UnknownNCT03190824What this trial is testingEvaluate Efficacy, Immunological Response of Intratumoral/Intralesional Oncolytic Virus (OBP-301) in Metastatic MelanomaWho this might be right forMelanoma Stage IIIMelanoma Stage Iv Syneos Health 4
Testing effectiveness (Phase 2)UnknownNCT02654821What this trial is testingStudy With T-cel Receptor Gene Therapy in Metastatic MelanomaWho this might be right forStage IV Skin MelanomaEye; Melanoma The Netherlands Cancer Institute 12
Early research (Phase 1)Study completedNCT01989559What this trial is testingBooster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By SurgeryWho this might be right forRecurrent MelanomaStage IA Skin MelanomaStage IB Skin Melanoma+7 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Ended earlyNCT04725331What this trial is testingA Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid TumorsWho this might be right forMetastatic CancerSoft Tissue SarcomaMerkel Cell Carcinoma+3 more Transgene 31
Testing effectiveness (Phase 2)Study completedNCT00306514What this trial is testingSafety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma PatientsWho this might be right forMelanoma Cytos Biotechnology AG
Testing effectiveness (Phase 2)Study completedNCT00035165What this trial is testingEPO906 Therapy in Patients With Advanced MelanomaWho this might be right forMelanoma Novartis Pharmaceuticals 51
Testing effectiveness (Phase 2)Looking for participantsNCT06708663What this trial is testingHX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid TumoursWho this might be right forBiliary Tract CancerMelanoma Hangzhou Hanx Biopharmaceuticals, Ltd. 124
Very early researchStudy completedNCT01748747What this trial is testingVaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By SurgeryWho this might be right forRecurrent MelanomaStage IIA MelanomaStage IIB Melanoma+5 more Mayo Clinic 30
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130